Establishment of a nationwide patient database for clinical trial recruitment in dermatology: Concept and patient characteristics

Dorra Bouazzi; Anette Bygum; Lone Skov; Mikkel Lindskov Sachs; Lars Iversen; Merete Haedersdal; Gregor B.E. Jemec; Simon Francis Thomsen

doi:10.2340/00015555-3800

Establishment of a nationwide patient database for clinical trial recruitment in dermatology: Concept and patient characteristics

Dorra Bouazzi, Anette Bygum, Lone Skov, Mikkel Lindskov Sachs, Lars Iversen, Merete Haedersdal, Gregor B.E. Jemec, Simon Francis Thomsen^*

^*Corresponding author for this work

Original language	English
Article number	adv00461
Journal	Acta Dermato-Venereologica
Volume	101
Issue number	5
Pages (from-to)	adv00461
ISSN	0001-5555
DOIs	https://doi.org/10.2340/00015555-3800
Publication status	Published - May 2021

Keywords

Dermatitis, Atopic
Dermatology
Humans
Psoriasis

Access to Document

10.2340/00015555-3800

Cite this

@article{1822b2ac2658410a938de93bef7929cc,

title = "Establishment of a nationwide patient database for clinical trial recruitment in dermatology: Concept and patient characteristics",

keywords = "Dermatitis, Atopic, Dermatology, Humans, Psoriasis",

author = "Dorra Bouazzi and Anette Bygum and Lone Skov and Sachs, {Mikkel Lindskov} and Lars Iversen and Merete Haedersdal and Jemec, {Gregor B.E.} and Thomsen, {Simon Francis}",

note = "Funding Information: The authors thank OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark. Funding Information: UCB. MH reports grants from Leo Pharma, grants from Procter and Gamble, non-financial support from Cherry Imaging, non-financial support from Cynosure-Hologic, grants and non-financial support from Lutronic, grants and non-financial support from Mirai Medical, grants and nonfinancial support from Novoxel, non-financial support from Perfaction Technologies, outside the submitted work. GBE Jemec has received honoraria from AbbVie, Chemocen-tryx, Coloplast, Incyte, Inflarx, Novartis, Pierre Fabre and UCB for participation on advisory boards, and grants from Abbvie, Astra-Zeneca, Inflarx, Janssen-Cilag, Leo Pharma, Novartis, Regeneron, Sanofi and UCB for participation as an investigator, and received speaker honoraria from AbbVie, Boehringer-Ingelheim and Galderma. He has also received unrestricted departmental grants from Abbvie, Leo Pharma and Novartis. SFT has received research support, been a speaker and served on advisory boards for Abbvie, Janssen, Novartis, Sanofi and UCB. DB and MKS have no conflicts of interest to declare.",

year = "2021",

month = may,

doi = "10.2340/00015555-3800",

language = "English",

volume = "101",

pages = "adv00461",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Forum for Nordic Dermato-Venereology",

number = "5",

}

TY - JOUR

T1 - Establishment of a nationwide patient database for clinical trial recruitment in dermatology

T2 - Concept and patient characteristics

AU - Bouazzi, Dorra

AU - Bygum, Anette

AU - Skov, Lone

AU - Sachs, Mikkel Lindskov

AU - Iversen, Lars

AU - Haedersdal, Merete

AU - Jemec, Gregor B.E.

AU - Thomsen, Simon Francis

N1 - Funding Information: The authors thank OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark. Funding Information: UCB. MH reports grants from Leo Pharma, grants from Procter and Gamble, non-financial support from Cherry Imaging, non-financial support from Cynosure-Hologic, grants and non-financial support from Lutronic, grants and non-financial support from Mirai Medical, grants and nonfinancial support from Novoxel, non-financial support from Perfaction Technologies, outside the submitted work. GBE Jemec has received honoraria from AbbVie, Chemocen-tryx, Coloplast, Incyte, Inflarx, Novartis, Pierre Fabre and UCB for participation on advisory boards, and grants from Abbvie, Astra-Zeneca, Inflarx, Janssen-Cilag, Leo Pharma, Novartis, Regeneron, Sanofi and UCB for participation as an investigator, and received speaker honoraria from AbbVie, Boehringer-Ingelheim and Galderma. He has also received unrestricted departmental grants from Abbvie, Leo Pharma and Novartis. SFT has received research support, been a speaker and served on advisory boards for Abbvie, Janssen, Novartis, Sanofi and UCB. DB and MKS have no conflicts of interest to declare.

PY - 2021/5

Y1 - 2021/5

KW - Dermatitis, Atopic

KW - Dermatology

KW - Humans

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=85107088987&partnerID=8YFLogxK

U2 - 10.2340/00015555-3800

DO - 10.2340/00015555-3800

M3 - Comment/debate

C2 - 33856041

AN - SCOPUS:85107088987

SN - 0001-5555

VL - 101

SP - adv00461

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 5

M1 - adv00461

ER -

Establishment of a nationwide patient database for clinical trial recruitment in dermatology: Concept and patient characteristics

Keywords

Access to Document

Other files and links

Cite this